{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T22:31:54Z","timestamp":1791757914676,"version":"4.3.4"},"reference-count":19,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,1,1]]},"abstract":"\n OBJECTIVE<\/jats:title>\n The authors previously evaluated risk and time course of adverse radiation effects (AREs) following stereotactic radiosurgery (SRS) for brain metastases, excluding lesions treated after prior SRS. In the present analysis they focus specifically on single-fraction salvage SRS to brain metastases previously treated with SRS or hypofractionated SRS (HFSRS), evaluating freedom from progression (FFP) and the risk and time course of AREs.<\/jats:p>\n <\/jats:sec>\n \n METHODS<\/jats:title>\n Brain metastases treated from September 1998 to May 2019 with single-fraction SRS after prior SRS or HFSRS were analyzed. Serial follow-up magnetic resonance imaging (MRI) and surgical pathology reports were reviewed to score local treatment failure and AREs. The Kaplan-Meier method was used to estimate FFP and risk of ARE measured from the date of repeat SRS with censoring at the last brain MRI.<\/jats:p>\n <\/jats:sec>\n \n RESULTS<\/jats:title>\n A total of 229 retreated brain metastases in 124 patients were evaluable. The most common primary cancers were breast, lung, and melanoma. The median interval from prior SRS\/HFSRS to repeat SRS was 15.4 months, the median prescription dose was 18 Gy, and the median duration of follow-up imaging was 14.5 months. At 1 year after repeat SRS, FFP was 80% and the risk of symptomatic ARE was 11%. The 1-year risk of imaging changes, including asymptomatic RE and symptomatic ARE, was 30%. Among lesions that demonstrated RE, the median time to onset was 6.7 months (IQR 4.7\u20139.9 months) and the median time to peak imaging changes was 10.1 months (IQR 5.6\u201313.6 months). Lesion size by quadratic mean diameter (QMD) showed similar results for QMDs ranging from 0.75 to 2.0 cm (1-year FFP 82%, 1-year risk of symptomatic ARE 11%). For QMD < 0.75 cm, the 1-year FFP was 86% and the 1-year risk of symptomatic ARE was only 2%. Outcomes were worse for QMDs 2.01\u20133.0 cm (1-year FFP 65%, 1-year risk of symptomatic ARE 24%). The risk of symptomatic ARE was not increased with tyrosine kinase inhibitors or immunotherapy before or after repeat SRS.<\/jats:p>\n <\/jats:sec>\n \n CONCLUSIONS<\/jats:title>\n RE on imaging was common after repeat SRS (30% at 1 year), but the risk of a symptomatic ARE was much less (11% at 1 year). The results of repeat single-fraction SRS were good for brain metastases \u2264 2 cm. The authors recommend an interval \u2265 6 months from prior SRS and a prescription dose \u2265 18 Gy. Alternatives such as HFSRS, laser interstitial thermal therapy, or resection with adjuvant radiation should be considered for recurrent brain metastases > 2 cm.<\/jats:p>\n <\/jats:sec>","DOI":"10.3171\/2022.4.jns212597","type":"journal-article","created":{"date-parts":[[2022,5,28]],"date-time":"2022-05-28T01:05:46Z","timestamp":1653699946000},"page":"104-112","source":"Crossref","is-referenced-by-count":27,"title":["Adverse radiation effect and freedom from progression following repeat stereotactic radiosurgery for brain metastases"],"prefix":"10.3171","volume":"138","author":[{"given":"Penny K.","family":"Sneed","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, University of California, San Francisco;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason W.","family":"Chan","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of California, San Francisco;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Southern California, Los Angeles;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve E.","family":"Braunstein","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of California, San Francisco;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip V.","family":"Theodosopoulos","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, University of California, San Francisco, California; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon E.","family":"Fogh","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of California, San Francisco;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean L.","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of California, San Francisco;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Boreta","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of California, San Francisco;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Raleigh","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of California, San Francisco;"},{"name":"Department of Neurological Surgery, University of California, San Francisco, California; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin P.","family":"Ziemer","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of California, San Francisco;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Morin","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of California, San Francisco;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn L.","family":"Hervey-Jumper","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, University of California, San Francisco, California; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"McDermott","sequence":"additional","affiliation":[{"name":"Division of Neurosurgery, Miami Neuroscience Institute, Baptist Health South Florida, Miami, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"issue":"2","key":"b1","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3171\/2014.10.JNS141610","article-title":"Adverse radiation effect after stereotactic radiosurgery for brain metastases: incidence, time course, and risk factors","volume":"123","author":"Sneed PK","year":"2015","unstructured":"Sneed PK, Mendez J, Vemer-van den Hoek JGM, Adverse radiation effect after stereotactic radiosurgery for brain metastases: incidence, time course, and risk factors. J Neurosurg. 2015;123(2):373\u2013386.2597871010.3171\/2014.10.JNS141610"},{"issue":"3","key":"b2","series-title":"Int J Radiat Oncol Biol Phys","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.ijrobp.2013.05.015","article-title":"Challenges with the diagnosis and treatment of cerebral radiation necrosis","volume":"87","author":"Chao ST","year":"2013","unstructured":"Chao ST, Ahluwalia MS, Barnett GH, Challenges with the diagnosis and treatment of cerebral radiation necrosis. Int J Radiat Oncol Biol Phys. 2013;87(3):449\u2013457.2379077510.1016\/j.ijrobp.2013.05.015"},{"issue":"suppl 1","key":"b3","series-title":"J Radiosurg SBRT","first-page":"66","article-title":"Quadratic mean diameter is highly significant in predicting tumor control for stereotactic radiosurgery of brain metastases. Abstract","volume":"3","author":"Ma L","year":"2015","unstructured":"Ma L, Chiu J, McDermott M, Sneed P. Quadratic mean diameter is highly significant in predicting tumor control for stereotactic radiosurgery of brain metastases. Abstract. J Radiosurg SBRT. 2015;3(suppl 1):66."},{"key":"b4","series-title":"Math Teach","doi-asserted-by":"publisher","first-page":"27","DOI":"10.5951\/MT.70.1.0027","article-title":"A further neglected mean","volume":"70","author":"Iles K","year":"1977","unstructured":"Iles K, Wilson L. A further neglected mean. Math Teach. 1977;70:27\u201328.10.5951\/MT.70.1.0027"},{"key":"b5","series-title":"Prog Neurol Surg","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1159\/000331200","article-title":"Management of recurrent brain metastasis after radiosurgery","volume":"25","author":"Stockham AL","year":"2012","unstructured":"Stockham AL, Suh JH, Chao ST, Barnett GH. Management of recurrent brain metastasis after radiosurgery. Prog Neurol Surg. 2012;25:273\u2013286.2223668810.1159\/000331200"},{"issue":"6","key":"b6","series-title":"PLoS One","doi-asserted-by":"publisher","first-page":"e0198692","DOI":"10.1371\/journal.pone.0198692","article-title":"Repeated in-field radiosurgery for locally recurrent brain metastases: feasibility, results and survival in a heavily treated patient cohort","volume":"13","author":"Balermpas P","year":"2018","unstructured":"Balermpas P, Stera S, M\u00fcller von der Gr\u00fcn J, Repeated in-field radiosurgery for locally recurrent brain metastases: feasibility, results and survival in a heavily treated patient cohort. PLoS One. 2018;13(6):e0198692.10.1371\/journal.pone.0198692"},{"issue":"3","key":"b7","series-title":"J Neurooncol","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s11060-019-03323-8","article-title":"Repeat stereotactic radiosurgery for the management of locally recurrent brain metastases","volume":"145","author":"Iorio-Morin C","year":"2019","unstructured":"Iorio-Morin C, Mercure-Cyr R, Figueiredo G, Touchette CJ, Masson-C\u00f4t\u00e9 L, Mathieu D. Repeat stereotactic radiosurgery for the management of locally recurrent brain metastases. J Neurooncol. 2019;145(3):551\u2013559.3166773210.1007\/s11060-019-03323-8"},{"issue":"1","key":"b8","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3171\/2016.5.JNS153051","article-title":"Repeat stereotactic radiosurgery as salvage therapy for locally recurrent brain metastases previously treated with radiosurgery","volume":"127","author":"McKay WH","year":"2017","unstructured":"McKay WH, McTyre ER, Okoukoni C, Repeat stereotactic radiosurgery as salvage therapy for locally recurrent brain metastases previously treated with radiosurgery. J Neurosurg. 2017;127(1):148\u2013156.2749481510.3171\/2016.5.JNS153051"},{"issue":"4","key":"b9","series-title":"PLoS One","doi-asserted-by":"publisher","first-page":"e0195608","DOI":"10.1371\/journal.pone.0195608","article-title":"Second course of stereotactic radiosurgery for locally recurrent brain metastases: safety and efficacy","volume":"13","author":"Moreau J","year":"2018","unstructured":"Moreau J, Khalil T, Dupic G, Second course of stereotactic radiosurgery for locally recurrent brain metastases: safety and efficacy. PLoS One. 2018;13(4):e0195608.2962134110.1371\/journal.pone.0195608"},{"key":"b10","series-title":"Front Oncol","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3389\/fonc.2017.00279","article-title":"Long-term outcomes after salvage stereotactic radiosurgery (SRS) following in-field failure of initial SRS for brain metastases","volume":"7","author":"Rana N","year":"2017","unstructured":"Rana N, Pendyala P, Cleary RK, Long-term outcomes after salvage stereotactic radiosurgery (SRS) following in-field failure of initial SRS for brain metastases. Front Oncol. 2017;7:279.2921830110.3389\/fonc.2017.00279"},{"issue":"4","key":"b11","series-title":"Neurooncol Pract","first-page":"400","article-title":"Predictors of radiation necrosis in long-term survivors after Gamma Knife stereotactic radiosurgery for brain metastases","volume":"7","author":"Siddiqui ZA","year":"2020","unstructured":"Siddiqui ZA, Squires BS, Johnson MD, Predictors of radiation necrosis in long-term survivors after Gamma Knife stereotactic radiosurgery for brain metastases. Neurooncol Pract. 2020;7(4):400\u2013408.32765891"},{"issue":"1","key":"b12","series-title":"J Radiosurg SBRT","first-page":"21","article-title":"Tumor control and incidence of radiation necrosis after reirradiation with stereotactic radiosurgery for brain metastases","volume":"3","author":"Terakedis BE","year":"2014","unstructured":"Terakedis BE, Jensen RL, Boucher K, Shrieve DC. Tumor control and incidence of radiation necrosis after reirradiation with stereotactic radiosurgery for brain metastases. J Radiosurg SBRT. 2014;3(1):21\u201328.29296381"},{"key":"b13","series-title":"World Neurosurg","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.wneu.2017.04.103","article-title":"Repeat stereotactic radiosurgery for locally recurrent brain metastases","volume":"104","author":"Koffer P","year":"2017","unstructured":"Koffer P, Chan J, Rava P, Repeat stereotactic radiosurgery for locally recurrent brain metastases. World Neurosurg. 2017;104:589\u2013593.2845023510.1016\/j.wneu.2017.04.103"},{"issue":"5","key":"b14","series-title":"J Korean Neurosurg Soc","doi-asserted-by":"publisher","first-page":"633","DOI":"10.3340\/jkns.2017.0238","article-title":"Repeat stereotactic radiosurgery for recurred metastatic brain tumors","volume":"61","author":"Kim IY","year":"2018","unstructured":"Kim IY, Jung S, Jung TY, Repeat stereotactic radiosurgery for recurred metastatic brain tumors. J Korean Neurosurg Soc. 2018;61(5):633\u2013639.3006420210.3340\/jkns.2017.0238"},{"key":"b15","series-title":"Crit Rev Oncol Hematol","doi-asserted-by":"publisher","first-page":"103043","DOI":"10.1016\/j.critrevonc.2020.103043","article-title":"Stereotactic reirradiation for local failure of brain metastases following previous radiosurgery: systematic review and meta-analysis","volume":"153","author":"Loi M","year":"2020","unstructured":"Loi M, Caini S, Scoccianti S, Stereotactic reirradiation for local failure of brain metastases following previous radiosurgery: systematic review and meta-analysis. Crit Rev Oncol Hematol. 2020;153:103043.3265021710.1016\/j.critrevonc.2020.103043"},{"issue":"3","key":"b16","series-title":"Int J Radiat Oncol Biol Phys","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.ijrobp.2021.10.008","article-title":"Reirradiation with stereotactic radiosurgery after local or marginal recurrence of brain metastases from previous radiosurgery","volume":"112","author":"Kowalchuk RO","year":"2022","unstructured":"Kowalchuk RO, Niranjan A, Lee CC, Reirradiation with stereotactic radiosurgery after local or marginal recurrence of brain metastases from previous radiosurgery. Int J Radiat Oncol Biol Phys. 2022;112(3):726\u2013734.10.1016\/j.ijrobp.2021.10.008"},{"issue":"6","key":"b17","series-title":"Lancet Oncol","doi-asserted-by":"publisher","first-page":"e270","DOI":"10.1016\/S1470-2045(15)70057-4","article-title":"Response assessment criteria for brain metastases: proposal from the RANO group","volume":"16","author":"Lin NU","year":"2015","unstructured":"Lin NU, Lee EQ, Aoyama H, Response assessment criteria for brain metastases: proposal from the RANO group. Lancet Oncol. 2015;16(6):e270\u2013e278.2606561210.1016\/S1470-2045(15)70057-4"},{"issue":"1","key":"b18","series-title":"J Neurooncol","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s11060-021-03802-x","article-title":"Bevacizumab vs laser interstitial thermal therapy in cerebral radiation necrosis from brain metastases: a systematic review and meta-analysis","volume":"154","author":"Palmisciano P","year":"2021","unstructured":"Palmisciano P, Haider AS, Nwagwu CD, Bevacizumab vs laser interstitial thermal therapy in cerebral radiation necrosis from brain metastases: a systematic review and meta-analysis. J Neurooncol. 2021;154(1):13\u201323.3421839610.1007\/s11060-021-03802-x"},{"issue":"suppl 5","key":"b19","series-title":"Neurooncol Adv","first-page":"v16","article-title":"Laser interstitial thermal therapy for brain metastases","volume":"3","author":"Srinivasan ES","year":"2021","unstructured":"Srinivasan ES, Grabowski MM, Nahed BV, Barnett GH, Fecci PE. Laser interstitial thermal therapy for brain metastases. Neurooncol Adv. 2021;3(suppl 5):v16\u2013v25.34859229"}],"container-title":["Journal of Neurosurgery"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/138\/1\/article-p104.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/138\/1\/article-p104.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/138\/1\/article-p104.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T08:14:50Z","timestamp":1732176890000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/138\/1\/article-p104.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,1]]},"references-count":19,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3171\/2022.4.jns212597","relation":{},"ISSN":["0022-3085","1933-0693"],"issn-type":[{"value":"0022-3085","type":"print"},{"value":"1933-0693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,1]]}}}